Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $244000.0.

  • Rockwell Medical's Change in Receivables rose 11243.0% to $244000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$549000.0, marking a year-over-year decrease of 1342.98%. This contributed to the annual value of -$2.6 million for FY2024, which is 15622.58% down from last year.
  • According to the latest figures from Q3 2025, Rockwell Medical's Change in Receivables is $244000.0, which was up 11243.0% from -$1.6 million recorded in Q2 2025.
  • Rockwell Medical's Change in Receivables' 5-year high stood at $4.0 million during Q3 2023, with a 5-year trough of -$2.0 million in Q3 2024.
  • For the 5-year period, Rockwell Medical's Change in Receivables averaged around $218789.5, with its median value being -$123000.0 (2021).
  • As far as peak fluctuations go, Rockwell Medical's Change in Receivables crashed by 80081.3% in 2022, and later skyrocketed by 64633.47% in 2023.
  • Rockwell Medical's Change in Receivables (Quarter) stood at -$123000.0 in 2021, then crashed by 800.81% to -$1.1 million in 2022, then skyrocketed by 238.99% to $1.5 million in 2023, then crashed by 138.05% to -$586000.0 in 2024, then skyrocketed by 141.64% to $244000.0 in 2025.
  • Its Change in Receivables was $244000.0 in Q3 2025, compared to -$1.6 million in Q2 2025 and $1.4 million in Q1 2025.